Home Healthcare Pharmaceuticals Radiotheranostics Market

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Thyroid Cancer, Neuroendocrine Tumor, Hepatocellular Carcinoma, Prostate Cancer, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 13, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
  7. North America Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
  8. Europe Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
  9. APAC Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
  10. Middle East and Africa Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
  11. LATAM Radiotheranostics Market Size Analysis
    1. Introduction
    2. Radiotheranostics Market Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
      1. Iodine-131
      2. Iodine-123
      3. Gallium-68
      4. Lutetium-177
      5. 18F with Y-90
      6. Others
    3. Radiotheranostics Market Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
      1. Targeted Therapeutic
      2. Targeted Diagnostic
    4. Radiotheranostics Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Thyroid Cancer
      3. Neuroendocrine Tumor
      4. Hepatocellular Carcinoma
      5. Prostate Cancer
      6. Others
        1. Neurological Disorders
        2. Arthritis
        3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      3. Market Size & Forecast By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
  12. Competitive Landscape
    1. Radiotheranostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Novartis AG (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bayer AG (Germany)
    3. Curium Pharma (France)
    4. Telix Pharmaceuticals (Australia)
    5. ITM Isotope Technologies Munich SE (Germany)
    6. Lantheus Holdings (US)
    7. POINT Biopharma Global Inc. (US)
    8. Fusion Pharmaceuticals (Canada)
    9. Actinium Pharmaceuticals (US)
    10. Radiopharm Theranostics (Australia)
    11. Clarity Pharmaceuticals (Australia)
    12. Perspective Therapeutics (US)
    13. GE HealthCare (US)
    14. SHINE Technologies (US)
    15. NorthStar Medical Radioisotopes (US)
    16. RadioMedix Inc. (US)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.